News
BSX
88.95
+0.33%
0.29
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Vivani Medical (VANI) and Merit Medical Systems (MMSI)
TipRanks · 1d ago
S&P 500 Analyst Moves: BSX
NASDAQ · 1d ago
Boston Scientific Updates Instructions for Cryoablation Balloons After Reports Of Severe Injuries
Benzinga · 1d ago
J.P. Morgan’s top Healthcare stocks for 2025
Seeking Alpha · 1d ago
Impax Global Social Leaders Fund Q3 2024 Commentary
Seeking Alpha · 1d ago
Medtronic Stock Declines 5.6% in a Month: Time to Buy the Dip?
Barchart · 1d ago
Do Boston Scientific's (NYSE:BSX) Earnings Warrant Your Attention?
Simply Wall St · 2d ago
All You Need to Know About Boston Scientific (BSX) Rating Upgrade to Buy
NASDAQ · 2d ago
SOXL, BMED: Big ETF Outflows
NASDAQ · 2d ago
Impax Global Opportunities Fund Q3 2024 Commentary
Seeking Alpha · 2d ago
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
NASDAQ · 2d ago
The Gabelli ABC Fund Q3 2024  Commentary
Seeking Alpha · 2d ago
Boston Sci issues safety recall for POLARx cryoablation catheters
Seeking Alpha · 3d ago
Least shorted S&P 500 stocks in November
Seeking Alpha · 3d ago
Boston Scientific Price Target Raised to $110.00/Share From $100.00 by Truist Securities
Dow Jones · 3d ago
Boston Scientific Is Maintained at Buy by Truist Securities
Dow Jones · 3d ago
Truist Securities Maintains Buy on Boston Scientific, Raises Price Target to $110
Benzinga · 3d ago
Boston Scientific price target raised to $110 from $100 at Truist
TipRanks · 3d ago
BSX Trades Near 52-Week High: Does the Stock Hold More Potential?
Barchart · 3d ago
Hartford Global Impact Fund Q3 2024 Commentary
Seeking Alpha · 3d ago
More
Webull provides a variety of real-time BSX stock news. You can receive the latest news about Boston Scien Cp through multiple platforms. This information may help you make smarter investment decisions.
About BSX
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. It also owns the transcarotid artery revascularization (TCAR) platform.